Healthcare

Australian Clinical Labs released its FY2026 results on 17 August, highlighting improving underlying profitability despite challenging pathology market conditions. Underlying EBIT increased 1.7%, while underlying NPAT rose 4.3%.Revenuedeclined slightly, reflecting weaker market growth and Medicare funding changes affecting selected tests. The company continues focusing …

Nexsen (ASX: NXN) shares rose 5.00% to AUD 0.21 at the time of writing on 1 September 2026. Nexsen Limited (ASX: NXN) is building its healthcare platform through clinical, manufacturing and regional partnerships. Its 2026 announcements have highlighted expansion across Asia-Pacific, with the company …

Algorae Pharmaceuticals (ASX: 1AI) shares rose 5.00% to AUD 0.011 at the time of writing on 1 September 2026. Algorae Pharmaceuticals Limited (ASX: 1AI) continues to operate across two connected areas: AI-enabled drug discovery and pharmaceutical commercialisation. Its 2026 announcements have covered the development …

Ceryvyn Therapeutics (ASX: CYV) shares rose 20.00% to AUD 0.012 at the time of writing on 1 September 2026. Ceryvyn Therapeutics Limited (ASX: CYV) is continuing its development strategy around lymphangioleiomyomatosis, or LAM, following a change in company name and ASX code during July …

Epsilon Healthcare (ASX: EPN) shares rose 14.29% to AUD 0.024 at the time of writing on 1 September 2026. Epsilon Healthcare Limited (ASX: EPN) reported a significant operating milestone in its 30 July 2026 quarterly activities report. The company recorded quarterly receipts of AUD …

Monash IVF Group is one of Australia's leading fertility services providers, operating a network of clinics, diagnostic laboratories and ultrasound services across Australia and internationally. The company has built itsBusinessaround assisted reproductive services, including IVF treatment cycles, genetic testing and specialist obstetric ultrasound, positioning …

Echo IQ is a healthtech company developing artificial intelligence-driven diagnostic technology focused on cardiac conditions, with its flagship product, EchoSolv HF, designed to assist in the detection and assessment of heart failure using AI analysis of echocardiogram data.